Blood News and Research

RSS

Life-prolonging effect of vitamin niacin demonstrated in roundworms

Who would not want to live a long and healthy life? A freely available food supplement could help in this respect, scientists from ETH Zurich have demonstrated in roundworms. Vitamin B3 - also known as niacin - and its metabolite nicotinamide in the worms' diet caused them to live for about one tenth longer than usual.

1 Oct 2013

Scientists move closer to growing therapeutic brain cells in laboratory

Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Discovery paves way for new therapeutic strategies to protect heart health of diabetes patients

UC Davis Health System researchers have identified for the first time a biological pathway that is activated when blood sugar levels are abnormally high and causes irregular heartbeats, a condition known as cardiac arrhythmia that is linked with heart failure and sudden cardiac death.

1 Oct 2013

Research reveals significant role of Axl receptor in progression, therapeutic resistance of AML

BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.

1 Oct 2013

Standoff between a mutated gene and normal counterpart keeps certain cancer cells alive

What keeps leukemia cells alive almost forever, able to continue dividing endlessly and aggressively? New research at the Weizmann Institute suggests that, in around a quarter of all leukemias, the cancer cells rely on an internal "balance of terror" to keep going.

1 Oct 2013

BGI Health to introduce NIFTY screening test to reduce miscarriages

BGI Health is marking Baby Loss Awareness Week (9-15 October) with the launch of a new non-invasive screening test for Down’s Syndrome and other conditions, which can reduce the risk of miscarriage significantly compared with other, potentially unnecessary invasive procedures, according to recent studies.

1 Oct 2013

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

A team led by scientists at The Scripps Research Institute has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin. The finding makes possible a deeper scientific understanding of the insulin secretion process—and how it fails in insulin disorders such as type 2 diabetes.

1 Oct 2013

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.

1 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Researchers show that men experience more harm than good from routine PSA screening

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented on Monday by Professor Mathieu Boniol, at the 2013 European Cancer Congress (ECC2013).

1 Oct 2013

Unique DNA markings on certain genes may 'predict' risk of developing head and neck cancer

Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.

1 Oct 2013

Liquid biopsy: New device could help doctors diagnose and treat cancers

A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood-and it can support the cells' growth for further analysis.

1 Oct 2013

Early-term births associated with higher neonatal morbidity, shows study

Early-term births (37 to 38 weeks gestation) are associated with higher neonatal morbidity (illness) and with more neonatal intensive care unit (NICU) or neonatology service admissions than term births (39 to 41 weeks gestation), according to a study by Shaon Sengupta, M.D., M.P.H., now of the Children's Hospital of Philadelphia and formerly of the University at Buffalo, N.Y., and colleagues.

1 Oct 2013

Use of cocaine may increase one's vulnerability to HIV infection

Cocaine use may increase one's vulnerability to HIV infection, according to a new research report published in the Journal of Leukocyte Biology. In the report, scientists show that cocaine alters immune cells, called "quiescent CD4 T cells," to render them more susceptible to the virus, and at the same time, to allow for increased proliferation of the virus.

1 Oct 2013

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

A diagnosis of multiple sclerosis (MS) is a hard lot. Patients typically get the diagnosis around age 30 after experiencing a series of neurological problems such as blurry vision, wobbly gait or a numb foot. From there, this neurodegenerative disease follows an unforgiving course.

1 Oct 2013

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant. A new research report published online in The FASEB Journal, offers hope to men who experience priapism. This condition, which is often seen in men with sickle cell disease, causes erections lasting so long that they cause permanent damage to the penis.

1 Oct 2013

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin.

1 Oct 2013

Biomedical professor receives 2013 Transformative Research Award from NIH

Cancer researchers have been limited by current imaging technology in their ability to detect not only structure and function of tumors, but also tumor cell circulation. A technology proposed by Lihong Wang, PhD, at Washington University in St. Louis, may hold the key to reaching this goal.

1 Oct 2013

Central BP achieves the same with less

Using central, rather than brachial, blood pressure (BP) to guide treatment decisions results in patients with hypertension being given less medication, show results from a randomized trial.

30 Sep 2013

Blood News and Research

Life-prolonging effect of vitamin niacin demonstrated in roundworms

Scientists move closer to growing therapeutic brain cells in laboratory

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Discovery paves way for new therapeutic strategies to protect heart health of diabetes patients

Research reveals significant role of Axl receptor in progression, therapeutic resistance of AML

Standoff between a mutated gene and normal counterpart keeps certain cancer cells alive

BGI Health to introduce NIFTY screening test to reduce miscarriages

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers show that men experience more harm than good from routine PSA screening

Unique DNA markings on certain genes may 'predict' risk of developing head and neck cancer

Liquid biopsy: New device could help doctors diagnose and treat cancers

Early-term births associated with higher neonatal morbidity, shows study

Use of cocaine may increase one's vulnerability to HIV infection

Biochemists discover promising vitamin D-based treatment that halts or reverse MS

Researchers develop C6 compound that prevents abnormalities linked with priapism in mice

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

Biomedical professor receives 2013 Transformative Research Award from NIH

Central BP achieves the same with less

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News